• NOVABIO MS10 - MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) 10mg × 10 Vials product image
  • NOVABIO MS10 - MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) 10mg × 10 Vials product image

MS10 | MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) 10mg × 10 Vials

NOVABIO · 10mg · MOTS-c · U.S. warehouse
NOVABIO MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) in the standalone 10mg format, 10 vials. Positioned as the entry listed format for pilot cellular-pathway screening and baseline response mapping. U.S. warehouse; estimated delivery 3–7 days.
$66
$91
Quantity
ADD TO CART
BUY IT NOW
  • Detail

    MS10 | MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) 10mg × 10 Vials

    MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) — SKU MS10 identifies the 10mg edition of MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) as a standalone catalogue product. The format is differentiated as the entry listed format, with a catalogue focus on pilot cellular-pathway screening and baseline response mapping.

    Why this 10mg format is distinct

    The relevant comparison domain is cellular-pathway and longevity-marker research. The listed strength is used to distinguish material quantity and research planning within this product family; it is not presented as a statement of clinical outcome.

    Product specifications

    • Brand: NOVABIO
    • SKU: MS10
    • Product: MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c)
    • Listed strength: 10mg
    • Package quantity: 10 vials

    Related catalogue

    Browse Anti-aging or review NOVABIO guides for product-name, strength and package comparisons.

    U.S. warehouse delivery

    Ships from our U.S. warehouse; estimated delivery is 3–7 days.

    Important information

    Use the current product label and accompanying documentation to confirm identity and listed specifications. This catalogue description does not provide medical or dosing instructions.

  • Customer Reviews
    No comments